New England Journal of Medicine· 2025Q1
İdiyopatik Normal Basınçlı Hidrosefali için Şant Tedavisinde Rastgele Kontrollü Bir Çalışma
A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus
- 60atıf
- Q1SCImago
- 2025yıl
Kısa özet
Beyin omurilik sıvısı (BOS) drenajına yanıt veren idiyopatik normal basınçlı hidrosefali hastalarında, şant tedavisi 3 ayda plaseboya kıyasla yürüme hızını 0,21 m/s ve Tinetti ölçeği skorlarını 2,4 puan artırdı.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- Şant tedavisi, 3 ayda plaseboya kıyasla yürüme hızını 0,21 m/s (P<0,001) ve Tinetti ölçeği skorlarını 2,4 puan (P=0,003) iyileştirdi.
- Montreal Bilişsel Değerlendirme (MoCA) veya Aşırı Aktif Mesane Anketör (Overactive Bladder Questionnaire) skorlarında anlamlı bir iyileşme gözlenmedi.
- Şant için seçilen hastalar, geçici BOS drenajı ile yürüme hızında iyileşme göstermişti.
- Yan etkiler arasında plasebo grubunda daha fazla düşme, ancak açık şant grubunda daha fazla subdural kanama ve pozisyonel baş ağrısı yer aldı.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
BACKGROUND: Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, but the effectiveness of shunting is unclear. METHODS: We conducted a double-blind, randomized, placebo-controlled trial involving participants selected for shunt surgery on the basis of gait-velocity improvement with cerebrospinal fluid (CSF) drainage. Participants were randomly assigned to an open-shunt valve setting (opening pressure, 110 mm of water) or a placebo valve setting (opening pressure, >400 mm of water) of a noninvasively adjustable shunt. The primary outcome was the change in gait velocity 3 months after surgery. Secondary outcomes were the change at 3 months in the Tinetti scale total score (range, 0 to 28; lower scores indicate worse gait and balance), Montreal Cognitive Assessment (MoCA) score (range, 0 to 30; lower scores indicate worse cognition), and Overactive Bladder Questionnaire score (range, 0 to 100; higher scores indicate worse urinary incontinence). RESULTS: A total of 99 participants underwent randomization and received the assigned intervention. At 3 months, gait velocity had increased in the open-shunt group (mean [±SD] change, 0.23±0.23 m per second; assessed in 49 participants) and was unchanged in the placebo group (mean change, 0.03±0.23 m per second; assessed in 49 participants), resulting in a treatment difference of 0.21 m per second (95% confidence interval, 0.12 to 0.31; P<0.001). A significantly greater improvement in the open-shunt group than the placebo group was seen for the Tinetti scale score (mean change, 2.9 points vs. 0.5 points; P = 0.003) but not the MoCA score (1.3 points vs. 0.3 points) or the Overactive Bladder Questionnaire score (-3.3 points vs. -1.5 points). The results regarding adverse events were mixed, with more participants in the placebo group reporting falls (46% vs. 24%), an equal percentage having cerebral bleeding (2% in both groups), and more participants in the open-shunt group having subdural bleeding (12% vs. 2%) and positional headaches (59% vs. 28%). CONCLUSIONS: Among participants with idiopathic normal-pressure hydrocephalus who had a response to temporary CSF drainage, shunting resulted in significant improvements at 3 months in gait velocity and a measure of gait and balance but not in measures of cognition or incontinence. (Funded by the National Institute of Neurological Disorders and Stroke and the Trial Innovation Network; PENS ClinicalTrials.gov number, NCT05081128.).
Yazarların özeti; kaynağından alınmıştır. New England Journal of Medicine, 2025 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Hücresel ve Moleküler Sinirbilim
Cellular and Molecular NeuroscienceNeuroscience